Biography

Prof. Kazumitsu Nawata

University of Tokyo, Japan


Email: [email protected]


Qualifications

1982-1986 Ph.D., Stanford University, USA

1981-1982 M.A., Pennsylvania State University, USA


Publications (Selected)

  1. Nawata, K., Ii, M., & Kassai, R. (2023). Over-and under-provision of diabetes screening: making more efficient use of healthcare resources. Public Policy Review, 19(1), 1-36.
  2. Nawata, K. (2022). Heart diseases, hypertension and effects of antihypertensive medications: Is hypertension a true risk factor of heart diseases?. Frontiers in Public Health, 10, 929840.
  3. Lee, B. Y., & Nawata, K. (2021). Risky Innovativeness: The Role of Myopic Management. Review of Integrative Business and Economics Research, 10(3), 1-17.
  4. Nawata, K. (2020) "Risk Factors Affecting Ischemic Stroke: Potential Side Effect of Antihypertensive Drugs", Health, 12, 437-455.
  5. Nawata, K., Sugano, H., and Kimura, M., “An analysis of the effects of blood pressure and antihypertensive drugs on heart disease,” Health, 2019, 11, 792-816.
  6. Nawata K, and Kimura, M., “Empirical studies of effects of high blood pressure on medical costs and heart disease: Is the 2017 ACC/AHA guideline supported by enough evidence?” Health, 2018, 10, 1498-1519.
  7. Nawata, K. and Kimura, M., “Does high systolic blood pressure truly increase medical expenditure?An empirical analysis of the new 2017 ACC/AHA hypertension guideline,” Health, 2018, 10, 1044-1065.
  8. Nawata, K., Sekizawa, Y.,and Kimura, M., “Evaluation of blood pressure control medicines using health and medical checkup data in Japan: Alternative methods for randomized controlled trials,” Health, 2018, 10, 587-603.
  9. Nawata, K. and Kimura, M.,“Evaluation of medical costs of kidney diseases and risk factors in Japan,” Health, 2017, 9, 1734-1749.
  10. Nawata, K. and Kimura, M., “An analysis of the medical costs of and factors affecting diabetes using the medical checkup and payment dataset in Japan: Can we reduce the prevalence of diabetes?,” Health, 2017, 9, 1113-1127.
  11. Nawata, K. and Kimura, M., “Reliability of blood pressure measurements: An analysis of the white coat effect and its fluctuations,” Health, 2017, 9, 506-519.
  12. Nawata, K., Matsumoto, A., Kajihara,R.,and Kimura,M., “Evaluation of the distribution of and factors affecting blood pressure using medical checkup data in Japan.” Health, 2017, 9, 124-137.
  13. Nawata K. and Kawabuchi, K., “A long term evaluation of the Japanese medical payment system for cataract surgeries: Did the medical policy reduce the long hospital stay in Japan?” Health, 2016, 8, 905-919.
  14. Nawata K. and Kawabuchi, K., “Did the revision of the Japanese medical payment system work properly? - An analysis of averages and variances of length of hospital stay for type 2 diabetes patients by individual hospital,” Health, 2016, 8, 505-517.
  15. Nawata K. and Kawabuchi, K., ”Comparison of the length of stay and medical expenditures among Japanese hospitals for type 2 diabetes treatments: The Box-Cox transformation model under heteroscedasticity,” Health, 2016, 8, 49-63.
  16. Nawata K. andKawabuchi, K., “An econometric analysis of hospital length of stay for cataract operations in Japan by the Box-Cox transformation model and Hausman tests: Evaluation of the 2010 revision of the medical payment system,” Open Journal of Applied Science, 2015, 5, No.9, 559-570.
  17. Nawata. K. and Kawabuchi, K., “Financial Sustainability of the Japanese Medical Payment System: Analysis of the Japanese Medical Expenditure for Educational Hospitalization of Patients with Type 2 Diabetes,” Health, 2015, 7, 1007-1021.
  18. Nawata. K. and Kawabuchi, K., “Evaluation of Length of Hospital Stay Joining Educational Programs for Type 2 DiabetesMellitus Patients: Can We Control Medical Costs in Japan?” Health, 2015, 7, 256-269.
  19. Nawata, K., Ii, M., Toyama, H., and Takahashi, T., "Evaluation of the Inclusive Payment System Based on the Diagnosis Procedure Combination with respect to Cataract Operations in Japan,"Health, Vol.1, 2009, No.2, 93-103.
  20. Nawata, K., Ii, M.,Ishiguro, A.,and Kawabuchi, K., “An analysis of the length of hospital stay for cataract patients in Japan using the discrete-type proportional hazard model,” Mathematics and Computers in Simulation. 2009, Vol. 79, 2889-2896.
  21. Nawata, K., Niita, A.,Watanabe, S.,and Kawabuchi, K.,“An Analysis of the Hip Fracture Treatments in Japan by the Discrete-Type Proportional Hazard and Ordered Probit Models,” Mathematics and Computers in Simulation, 2008, Vol. 78, No. 2&3, 303–312.
  22. Nawata, K., Niita, A., Watanabe, A.,and Kawabuchi, K., "An Analysis of the Length of Stay and the Effectiveness of Treatment for Hip Fractured Patients in Japan: Evaluation of the Revision of the 2002 Medical Service Fee Schedule," Journal of Health Economics, 2006, Vol. 25, No.4, 722-739.
  23. Nawata, K., "Estimation of Sample Selection Bias Models by the Maximum Likelihood Estimator and Heckman's Two-Step Estimator," Economic Letters, 1994, Vol. 45, 33-40.


Profile Details

https://scholar.google.co.jp/citations?user=FYAKfT4AAAAJ&hl=en
https://loop.frontiersin.org/people/1728200/overview
https://www.researchgate.net/profile/Kazumitsu-Nawata

SCIRP Newsletter
Copyright © 2006-2026 Scientific Research Publishing Inc. All Rights Reserved.
Top